Huadong Medicine: Legal Opinion of Zhejiang TianCe Law Firm on the Adjustment of Restricted Stock Grant Price and Redemption and Cancellation of Restricted Stocks of Huadong Medicine Co., Ltd.'s Restricted Stock Incentive Plan for 2022.

SZSI · Jun 14

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

华东医药：浙江天册律师事务所关于华东医药股份有限公司2022年限制性股票激励计划调整限制性股票回购价格及回购注销部分限制性股票的法律意见书

Huadong Medicine: Legal Opinion of Zhejiang TianCe Law Firm on the Adjustment of Restricted Stock Grant Price and Redemption and Cancellation of Restricted Stocks of Huadong Medicine Co., Ltd.'s Restricted Stock Incentive Plan for 2022.

Risk Disclaimer

Statement